+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Celiac Disease Treatment Market Size, Share & Trends Analysis Report by Treatment (Vitamins & Minerals, Gluten Degrading Enzymes), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), and Region with Growth Forecasts, 2025-2030- Product Image
Celiac Disease Treatment Market Size, Share & Trends Analysis Report by Treatment (Vitamins & Minerals, Gluten Degrading Enzymes), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), and Region with Growth Forecasts, 2025-2030- Product Image
New

Celiac Disease Treatment Market Size, Share & Trends Analysis Report by Treatment (Vitamins & Minerals, Gluten Degrading Enzymes), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 100 Pages
  • February 2025
  • Region: Global
  • Grand View Research
  • ID: 6032582
Description Jump to:
The Celiac Disease Treatment Market was valued at USD 690.2 million in 2024, and is projected to reach USD 1.34 billion by 2030, rising at a CAGR of 11.70%. Foremost among these is the escalating prevalence of diagnosed celiac disease cases globally. According to recent estimates, approximately 1 in 100 Americans suffers from celiac disease, although a significant proportion of cases remain undiagnosed. This rise in diagnosed instances, attributed to increased awareness and improved diagnostic capabilities, directly translates into a greater demand for effective treatments and diagnostic methodologies. The market benefits from this increasing patient base, driving pharmaceutical innovation and expanding the need for specialized dietary management.

As public knowledge about celiac disease symptoms and the crucial role of early diagnosis continues to grow, individuals are increasingly proactively seeking medical consultations and testing, thereby contributing to the increased identification of cases. Notably, a 2023 survey by Beyond Celiac revealed that only approximately 50% of Americans know anything about celiac disease or gluten sensitivity, indicating a growing awareness gap that needs to be bridged. However, the expanding gluten-free food industry offers a diverse range of dietary options for individuals managing the disease. The availability of these products plays a significant role in patient adherence to dietary restrictions, thereby improving health outcomes and contributing to market growth.

Improvements in detection methods, such as advancements in point-of-care testing (POCT), have facilitated earlier identification and intervention, leading to quicker and more effective treatment. Government initiatives across numerous nations, including screening programs targeting high-risk demographics, further bolster market development. These proactive measures increase the number of diagnosed cases and provide patients with timely access to diagnostics and treatment options, thereby promoting a more comprehensive and proactive healthcare approach. Notably, various countries have implemented programs to raise awareness about celiac disease and enhance access to diagnostics and treatment, underscoring the commitment to addressing this growing health concern.

Ongoing research into new therapeutic modalities assures novel developments in the treatment of celiac disease in the coming years. The development of anti-inflammatory drugs and therapeutic vaccines is expected to enhance treatment options and expand market opportunities. Furthermore, increasing healthcare expenditure and robust R&D activities, particularly in novel treatment alternatives, are poised to drive market expansion. Key players are increasingly investing in drugs and gluten-free products, indicating an emphasis on improving patient health, driving market penetration, and catering to an expanding consumer base.

Global Celiac Disease Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the global celiac disease treatment market report based on treatment, distribution channel, and region:

Treatment Outlook (Revenue, USD Million, 2018-2030)

  • Vitamins & Minerals
  • Gluten Degrading Enzymes
  • Symptomatic Treatment (Anti-inflammatory Drugs, Antihistamines, Others)
  • Other Treatments

Distribution Channel Outlook (Revenue, USD Million, 2018-2030)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels

Regional Outlook (Revenue, USD Million, 2018-2030)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

This report addresses:

  • Market intelligence to enable effective decision-making.
  • Market estimates and forecasts from 2018 to 2030.
  • Growth opportunities and trend analyses.
  • Segment and regional revenue forecasts for market assessment.
  • Competition strategy and market share analysis.
  • Product innovation listings for you to stay ahead of the curve.
  • COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Treatment
1.2.2. Distribution Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Celiac Disease Treatment Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
Chapter 4. Celiac Disease Treatment Market: Treatment Business Analysis
4.1. Treatment Market Share, 2024 & 2030
4.2. Treatment Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
4.4. Vitamins & Minerals
4.4.1. Vitamins & Minerals Market, 2018-2030 (USD Million)
4.5. Gluten Degrading Enzymes
4.5.1. Gluten Degrading Enzymes Market, 2018-2030 (USD Million)
4.6. Symptomatic Treatment (Anti-inflammatory Drugs, Antihistamines, Others)
4.6.1. Symptomatic Treatment (Anti-inflammatory Drugs, Antihistamines, Others) Market, 2018-2030 (USD Million)
4.7. Other Treatments
4.7.1. Other Treatments Market, 2018-2030 (USD Million)
Chapter 5. Celiac Disease Treatment Market: Distribution Channel Business Analysis
5.1. Distribution Channel Market Share, 2024 & 2030
5.2. Distribution Channel Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
5.4. Hospital Pharmacies
5.4.1. Hospital Pharmacies Market, 2018-2030 (USD Million)
5.5. Retail Pharmacies
5.5.1. Retail Pharmacies Market, 2018-2030 (USD Million)
5.6. Other Distribution Channels
5.6.1. Other Distribution Channels Market, 2018-2030 (USD Million)
Chapter 6. Celiac Disease Treatment Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America Celiac Disease Treatment Market Estimates And Forecasts, by Country, 2018-2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Framework
6.4.2.3. Competitive Insights
6.4.2.4. U.S. Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Framework
6.4.3.3. Competitive Insights
6.4.3.4. Canada Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Regulatory Framework
6.4.4.3. Competitive Insights
6.4.4.4. Mexico Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.5. Europe
6.5.1. Europe Celiac Disease Treatment Market Estimates And Forecasts, by Country, 2018-2030 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Framework
6.5.2.3. Competitive Insights
6.5.2.4. UK Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Framework
6.5.3.3. Competitive Insights
6.5.3.4. Germany Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Framework
6.5.4.3. Competitive Insights
6.5.4.4. France Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Regulatory Framework
6.5.5.3. Competitive Insights
6.5.5.4. Italy Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Regulatory Framework
6.5.6.3. Competitive Insights
6.5.6.4. Spain Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.5.7. Norway
6.5.7.1. Key Country Dynamics
6.5.7.2. Regulatory Framework
6.5.7.3. Competitive Insights
6.5.7.4. Norway Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.5.8. Denmark
6.5.8.1. Key Country Dynamics
6.5.8.2. Regulatory Framework
6.5.8.3. Competitive Insights
6.5.8.4. Denmark Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.5.9. Sweden
6.5.9.1. Key Country Dynamics
6.5.9.2. Regulatory Framework
6.5.9.3. Competitive Insights
6.5.9.4. Sweden Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Celiac Disease Treatment Market Estimates And Forecasts, by Country, 2018-2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Framework
6.6.2.3. Competitive Insights
6.6.2.4. Japan Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Framework
6.6.3.3. Competitive Insights
6.6.3.4. China Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Framework
6.6.4.3. Competitive Insights
6.6.4.4. India Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Framework
6.6.5.3. Competitive Insights
6.6.5.4. South Korea Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.6.6. Australia
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Framework
6.6.6.3. Competitive Insights
6.6.6.4. Australia Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Regulatory Framework
6.6.7.3. Competitive Insights
6.6.7.4. Thailand Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Celiac Disease Treatment Market Estimates And Forecasts, by Country, 2018-2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Framework
6.7.2.3. Competitive Insights
6.7.2.4. Brazil Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Framework
6.7.3.3. Competitive Insights
6.7.3.4. Argentina Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.8. MEA
6.8.1. MEA Celiac Disease Treatment Market Estimates And Forecasts, by Country, 2018-2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Framework
6.8.2.3. Competitive Insights
6.8.2.4. South Africa Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Regulatory Framework
6.8.3.3. Competitive Insights
6.8.3.4. Saudi Arabia Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Regulatory Framework
6.8.4.3. Competitive Insights
6.8.4.4. UAE Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Regulatory Framework
6.8.5.3. Competitive Insights
6.8.5.4. Kuwait Celiac Disease Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Teva Pharmaceutical Industries Ltd.
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Amgen Inc.
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Amneal Pharmaceuticals LLC.
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. GLENMARK PHARMACEUTICALS LTD.
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Takeda Pharmaceutical Company Limited
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. Hikma Pharmaceuticals PLC
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. Viatris Inc.
7.5.7.1. Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. Zydus Pharmaceuticals, Inc.
7.5.8.1. Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Novartis Pharmaceuticals Corporation
7.5.9.1. Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. BioLineRx
7.5.10.1. Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global celiac disease treatment market, by region, 2018-2030 (USD Million)
Table 4 Global celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 5 Global celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 6 North America celiac disease treatment market, by country, 2018-2030 (USD Million)
Table 7 North America celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 8 North America celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 9 U.S. celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 10 U.S. Celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 11 Canada celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 12 Canada celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 13 Mexico celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 14 Mexico celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 15 Europe celiac disease treatment market, by country, 2018-2030 (USD Million)
Table 16 Europe celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 17 Europe celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 18 UK celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 19 UK Celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 20 Germany celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 21 Germany celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 22 France celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 23 France Celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 24 Italy celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 25 Italy celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 26 Spain celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 27 Spain celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 28 Norway celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 29 Norway Celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 30 Denmark celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 31 Denmark celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 32 Sweden celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 33 Sweden celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 34 Asia Pacific celiac disease treatment market, by country, 2018-2030 (USD Million)
Table 35 Asia Pacific celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 36 Asia Pacific celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 37 Japan celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 38 Japan celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 39 China celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 40 China celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 41 India celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 42 India celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 43 Australia celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 44 Australia celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 45 South Korea celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 46 South Korea celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 47 Thailand celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 48 Thailand celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 49 Latin America celiac disease treatment market, by country, 2018-2030 (USD Million)
Table 50 Latin America celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 51 Latin America celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 52 Brazil celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 53 Brazil celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 54 Argentina celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 55 Argentina celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 56 Middle East & Africa Celiac disease treatment market, by country, 2018-2030 (USD Million)
Table 57 Middle East & Africa celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 58 Middle East & Africa celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 59 South Africa celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 60 South Africa celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 61 Saudi Arabia celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 62 Saudi Arabia celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 63 UAE celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 64 UAE celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
Table 65 Kuwait celiac disease treatment market, by treatment, 2018-2030 (USD Million)
Table 66 Kuwait celiac disease treatment market, by distribution channel, 2018-2030 (USD Million)
List of Figures
Figure 1 Celiac disease treatment market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 Market formulation & validation
Figure 8 Market snapshot
Figure 9 Treatment and distribution channel outlook (USD Million)
Figure 10 Competitive landscape
Figure 11 Celiac disease treatment market dynamics
Figure 12 Celiac disease treatment market: Porter’s five forces analysis
Figure 13 Celiac disease treatment market: PESTLE analysis
Figure 14 Celiac disease treatment market: Treatment segment dashboard
Figure 15 Celiac disease treatment market: Treatment market share analysis, 2024 & 2030
Figure 16 Vitamins & minerals market, 2018-2030 (USD Million)
Figure 17 Gluten degrading enzymes market, 2018-2030 (USD Million)
Figure 18 Symptomatic treatment (anti-inflammatory drugs, antihistamines, others) market, 2018-2030 (USD Million)
Figure 19 Other treatments market, 2018-2030 (USD Million)
Figure 20 Celiac disease treatment market: Distribution channel segment dashboard
Figure 21 Celiac disease treatment market: Distribution channel market share analysis, 2024 & 2030
Figure 22 Hospital pharmacies market, 2018-2030 (USD Million)
Figure 23 Retail pharmacies market, 2018-2030 (USD Million)
Figure 24 Other distribution channels market, 2018-2030 (USD Million)
Figure 25 Celiac disease treatment market revenue, by region
Figure 26 Regional marketplace: Key takeaways
Figure 27 Regional marketplace: Key takeaways
Figure 28 North America celiac disease treatment market, 2018-2030 (USD Million)
Figure 29 U.S. country dynamics
Figure 30 U.S. celiac disease treatment market, 2018-2030 (USD Million)
Figure 31 Canada country dynamics
Figure 32 Canada celiac disease treatment market, 2018-2030 (USD Million)
Figure 33 Mexico country dynamics
Figure 34 Mexico celiac disease treatment market, 2018-2030 (USD Million)
Figure 35 Europe celiac disease treatment market, 2018-2030 (USD Million)
Figure 36 UK country dynamics
Figure 37 UK celiac disease treatment market, 2018-2030 (USD Million)
Figure 38 Germany country dynamics
Figure 39 Germany celiac disease treatment market, 2018-2030 (USD Million)
Figure 40 France country dynamics
Figure 41 France celiac disease treatment market, 2018-2030 (USD Million)
Figure 42 Italy country dynamics
Figure 43 Italy celiac disease treatment market, 2018-2030 (USD Million)
Figure 44 Spain country dynamics
Figure 45 Spain celiac disease treatment market, 2018-2030 (USD Million)
Figure 46 Norway country dynamics
Figure 47 Norway celiac disease treatment market, 2018-2030 (USD Million)
Figure 48 Sweden country dynamics
Figure 49 Sweden celiac disease treatment market, 2018-2030 (USD Million)
Figure 50 Denmark country dynamics
Figure 51 Denmark celiac disease treatment market, 2018-2030 (USD Million)
Figure 52 Asia Pacific celiac disease treatment market, 2018-2030 (USD Million)
Figure 53 Japan country dynamics
Figure 54 Japan celiac disease treatment market, 2018-2030 (USD Million)
Figure 55 China country dynamics
Figure 56 China celiac disease treatment market, 2018-2030 (USD Million)
Figure 57 India country dynamics
Figure 58 India celiac disease treatment market, 2018-2030 (USD Million)
Figure 59 Australia country dynamics
Figure 60 Australia celiac disease treatment market, 2018-2030 (USD Million)
Figure 61 South Korea country dynamics
Figure 62 South Korea celiac disease treatment market, 2018-2030 (USD Million)
Figure 63 Thailand country dynamics
Figure 64 Thailand celiac disease treatment market, 2018-2030 (USD Million)
Figure 65 Latin America celiac disease treatment market, 2018-2030 (USD Million)
Figure 66 Brazil country dynamics
Figure 67 Brazil celiac disease treatment market, 2018-2030 (USD Million)
Figure 68 Argentina country dynamics
Figure 69 Argentina celiac disease treatment market, 2018-2030 (USD Million)
Figure 70 MEA celiac disease treatment market, 2018-2030 (USD Million)
Figure 71 South Africa country dynamics
Figure 72 South Africa celiac disease treatment market, 2018-2030 (USD Million)
Figure 73 Saudi Arabia country dynamics
Figure 74 Saudi Arabia celiac disease treatment market, 2018-2030 (USD Million)
Figure 75 UAE country dynamics
Figure 76 UAE celiac disease treatment market, 2018-2030 (USD Million)
Figure 77 Kuwait country dynamics
Figure 78 Kuwait celiac disease treatment market, 2018-2030 (USD Million)
Figure 79 Company categorization
Figure 80 Company market position analysis
Figure 81 Strategic framework

Companies Mentioned

The major companies profiled in this Celiac Disease Treatment market report include:
  • Teva Pharmaceutical Industries Ltd.
  • Amgen Inc.
  • Amneal Pharmaceuticals LLC.
  • GLENMARK PHARMACEUTICALS LTD.
  • Takeda Pharmaceutical Company Limited.
  • Hikma Pharmaceuticals PLC
  • Viatris Inc.
  • Zydus Pharmaceuticals, Inc.
  • Novartis Pharmaceuticals Corporation
  • BioLineRx Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages100
PublishedFebruary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 690.2 Million
Forecasted Market Value ( USD ) by 2030 $ 1340 Million
Compound Annual Growth Rate11.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Celiac Disease Drugs Market by Drug, Type, Indication, End-User - Global Forecast 2025-2030 - Product Image

Celiac Disease Drugs Market by Drug, Type, Indication, End-User - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Celiac Disease Treatment Market by Treatment, by Route of Administration, by Distribution Channel, and By Region - Product Image

Celiac Disease Treatment Market by Treatment, by Route of Administration, by Distribution Channel, and By Region

  • Report
  • 200 Pages
  • Global
From
Celiac Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Celiac Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 132 Pages
  • Global
From
Celiac Diseases Drugs Market 2024-2028 - Product Image

Celiac Diseases Drugs Market 2024-2028

  • Report
  • 162 Pages
  • Global
From
Celiac Disease - Pipeline Insight, 2024 - Product Image

Celiac Disease - Pipeline Insight, 2024

  • Clinical Trials
  • 115 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.